Suchergebnisse - "Libri, Vincenzo"

PubPharm (86)

1

Accurate evaluation of live-virus microneutralization for SARS-CoV-2 variant JN.1

enthalten in: bioRxiv.org | 2024

von Dowgier, G. | Hobbs, A. | Greenwood, D. | +16

2

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign

enthalten in: Lancet (London, England) | 2024

von Shawe-Taylor, M. | Greenwood, D. | Hobbs, A. | +18

3

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history

enthalten in: PloS one | 2024

von Townsley, H. | Gahir, J. | Russell, T. | +34

4

SARS-CoV-2 mucosal neutralising immunity after vaccination

enthalten in: The Lancet. Infectious diseases | 2023

von Carr, E. | Dowgier, G. | Greenwood, D. | +35

5

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults : a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland

enthalten in: The Lancet. Microbe | 2023

von Ramasamy, M. | Kelly, E. | Seegobin, S. | +51

6

A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2023

von Payne, T. | Appleby, M. | Buckley, E. | +16

7

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK : eight-month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2023

von Liu, X. | Munro, A. | Wright, A. | +59

8

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

enthalten in: The Lancet. Infectious diseases | 2023

von Carr, E. | Wu, M. | Gahir, J. | +33

9

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

enthalten in: The Journal of infection | 2023

von Shaw, R. | Greenland, M. | Stuart, A. | +38

10

Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults

enthalten in: bioRxiv.org | 2023

von Carr, E. | Townsley, H. | Wu, M. | +36

1
2
3
4
5
6
7
8
9
Nächster »
[9]